Page last updated: 2024-09-03

ms 857 and Cardiac Failure

ms 857 has been researched along with Cardiac Failure in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iwase, M; Nagata, K; Sobue, T; Yokota, M1
Kaiho, T; Kamiya, J; Kobari, T; Maruyama, M1

Trials

1 trial(s) available for ms 857 and Cardiac Failure

ArticleYear
Differential effects of dobutamine and a phosphodiesterase inhibitor on early diastolic filling in patients with congestive heart failure.
    Journal of the American College of Cardiology, 1995, Volume: 25, Issue:2

    Topics: Administration, Oral; Blood Flow Velocity; Cardiac Catheterization; Coronary Circulation; Diastole; Dobutamine; Echocardiography, Doppler, Pulsed; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Isoquinolines; Male; Middle Aged; Phosphodiesterase Inhibitors; Tetrahydroisoquinolines; Ventricular Function, Left

1995

Other Studies

1 other study(ies) available for ms 857 and Cardiac Failure

ArticleYear
Cardiovascular properties of MS-857, a new and potent cardiotonic agent, on normal and failing hearts.
    Journal of cardiovascular pharmacology, 1988, Volume: 12, Issue:5

    Topics: Anesthesia; Animals; Cardiotonic Agents; Dogs; Female; Heart; Heart Failure; Isoquinolines; Lung; Male; Myocardium; Pentobarbital; Phosphoric Diester Hydrolases; Propranolol; Sodium-Potassium-Exchanging ATPase; Stereoisomerism; Tetrahydroisoquinolines

1988
chemdatabank.com